APA

Albala D., Manak M. S., Varsanik J. S., Rashid H. H., Mouraviev V., Zappala S. M., Ette E., Kella N., Rieger-Christ K. M., Sant G. R. & Chander A. C. (20190514). Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4). : Urology.

Chicago

Albala David, Manak Michael S, Varsanik Jonathan S, Rashid Hani H, Mouraviev Vladimir, Zappala Stephen M, Ette Ene, Kella Naveen, Rieger-Christ Kimberly M, Sant Grannum R and Chander Ashok C. 20190514. Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4). : Urology.

Harvard

Albala D., Manak M. S., Varsanik J. S., Rashid H. H., Mouraviev V., Zappala S. M., Ette E., Kella N., Rieger-Christ K. M., Sant G. R. and Chander A. C. (20190514). Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4). : Urology.

MLA

Albala David, Manak Michael S, Varsanik Jonathan S, Rashid Hani H, Mouraviev Vladimir, Zappala Stephen M, Ette Ene, Kella Naveen, Rieger-Christ Kimberly M, Sant Grannum R and Chander Ashok C. Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4). : Urology. 20190514.